Filing Details

Accession Number:
0001209191-18-056808
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-01 17:25:44
Reporting Period:
2018-10-30
Accepted Time:
2018-11-01 17:25:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659323 Iterum Therapeutics Plc ITRM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1734389 Mark Chin C/o Iterum Therapeutics Plc, Blk 2
Fl. 3, Harcourt Centre, Harcourt St.
Dublin L2 2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-10-30 58,000 $6.10 1,089,903 No 4 P Indirect By Arix Bioscience Holdings Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Arix Bioscience Holdings Ltd.
Footnotes
  1. The Reporting Person is an Investment Director for Arix Bioscience Holdings Ltd.